Yoshihiko Taniguchi - Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center

基本信息

浏览量：52

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 135 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Baseline Genetic Abnormalities and Effectiveness of Osimertinib Treatment in Patients with Chemotherapy-Naïve EGFR-mutated NSCLC Based on Performance Status

Yoshihiko Taniguchi,Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa, Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

BMC Pulmonary Medicineno. 1 (2024): 1-6

引用0浏览0WOS引用

Abstract 964: Updated results of a prospective observational multicenter study on resistance mechanisms to osimertinib using circulating tumor DNA analyses in EGFR-mutated non-small cell lung cancer patients (ELUCIDATOR study)

Mitsuo Osuga,Akihiro Tamiya,Daijiro Harada,Yasuyuki Mizumori,Shun-ichi Isa,Yoshihiko Taniguchi, Keiichi Nakamura, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori, Tomohito Kuwako, Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

Cancer Researchno. 6_Supplement (2024): 964-964

引用0浏览0引用

Cryptogenic Organizing Pneumonia: Clinical Outcomes of 60 Consecutive Cases

Yoshihiko Taniguchi,Toru Arai,Taisuke Tsuji,Chikatoshi Sugimoto,Kazunobu Tachibana,Masanori Akira,Yoshikazu Inoue

JOURNAL OF THORACIC DISEASEno. 5 (2024): 3129-+

引用0浏览0WOS引用

Elements of End-of-Life Discussions Associated with Patients' Reported Outcomes and Actual End-of-Life Care in Patients with Pretreated Lung Cancer

Takaaki Hasegawa,Toru Okuyama,Takehiro Uemura,Yoshinobu Matsuda,Hiroyuki Otani,Junichi Shimizu,Yoshitsugu Horio,Naohiro Watanabe,Teppei Yamaguchi,Satoshi Fukuda,Tetsuya Oguri,Ken Maeno,Yoshihiko Taniguchi,Kaname Nosaki,Kensuke Fukumitsu,Tatsuo Akechi

ONCOLOGIST（2024）

引用0浏览0WOS引用

First report of ELUCIDATOR study: A prospective observational multicenter study on resistance mechanisms in patients with early disease progression during osimertinib

Yasuyuki Mizumori,Akihiro Tamiya,Mitsuo Osuga,Shun-ichi Isa,Yoshihiko Taniguchi, Keiichi Nakamura,Daijiro Harada, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori, Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 3032-3032

引用0浏览0引用

Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting

Akihiro Tamiya,Motohiro Tamiya,Yuji Inagaki,Yoshihiko Taniguchi,Keiko Nakao,Yoshinobu Matsuda,Takahisa Kawamura,Kei Kunimasa,Takako Inoue,Kazumi Nishino,Kyoichi Okishio

Anticancer research（2023）

引用0浏览0WOS引用

Possible False Results with Cobas® EGFR Mutation Test V2 and Oncomine Dx Target Test for EGFR Mutation

Kensuke Kanaoka,Akihiro Tamiya,Yuji Inagaki,Yoshihiko Taniguchi,Keiko Nakao,Maiko Takeda,Yoshinobu Matsuda,Kyoichi Okishio,Shigeki Shimizu

Anticancer Research/Anticancer research（2023）

引用0浏览0WOS引用

Osteoblastic Bone Reaction in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation Treated with Osimertinib

Kensuke Kanaoka,Hiromitsu Sumikawa,Shunsuke Oyamada,Akihiro Tamiya,Yuji Inagaki,Yoshihiko Taniguchi,Keiko Nakao,Yoshinobu Matsuda,Kyoichi Okishio

BMC CANCER（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn